Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

PaperCitations, authors & open-access status

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 240 citations, 2018 year and closed oa status.

240
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Samy Hadjadj
Author
Edoardo Mannucci
Author
Ofri Mosenzon
Author
Robert S. Busch
Author
Diabetes Care
Journal
Diabetes Management and Research
Topic
470M+ articles · free account